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rv1098c, an essential gene in Mycobacterium tuberculosis, codes for a class II fumarase. We describe
here the crystal structure of Rv1098c in complex with L-malate, fumarate or the competitive inhib-
itor meso-tartrate. The models reveal that substrate binding promotes the closure of the active site
through conformational changes involving the catalytic SS-loop and the C-terminal domain, which
likely represents a general feature of this enzyme superfamily. Analysis of ligand–enzyme interac-
tions as well as site-directed mutagenesis suggest Ser318 as one of the two acid–base catalysts.
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Rv1098c and Rv1098c bind by X-ray crystallography (View interaction)
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Ubiquitous enzymes, fumarases (fumarate hydratases: EC
4.2.1.2) catalyze the reversible hydratation of fumarate to
L-malate during the tricarboxylic acid cycle [1]. Two classes of
fumarases are known. Class I fumarases are composed of
heat-labile, iron–sulfur (4Fe–4S) homodimeric enzymes that
are only found in prokaryotes. Class II fumarases are made of
thermostable homotetrameric enzymes [2] found both in
prokaryotes and in eukaryotic mitochondria, and belong to a
superfamily that also includes aspartate-ammonia lyases, argin-
inosuccinatases, d-crystallins and 3-carboxy-cis,cis-muconate
lactonizing enzymes. All these enzymes participate in reactions
in which fumarate is released from different substrates, ranging
from adenylosuccinate to malate [3–6]. Despite limited se-
quence similarity, several crystal structures revealed an overall
conserved homotetrameric fold in which a central, elongatedchemical Societies. Published by E
ur, Unité de Microbiologie
75724 Paris cedex 15, France.
ellinzoni).20-helix bundle is created by the tight parallel packing of ﬁve
long helices at the center of each protomer, and is capped by
two smaller N-terminal and C-terminal domains, also mostly
a-helical. Most of the structural information on class II fumaras-
es has been obtained from the work on Escherichia coli FumC,
the ﬁrst member of the family whose structure has been solved
[7]. The model displayed bound tungstate, a known competitive
inhibitor, which in turn allowed the identiﬁcation of the active
site [7]. In addition, the structure of the enzyme was also
solved in complex with known inhibitors such as citrate [8],
PMA (pyromellitic acid) and TMSM (b-(trimethylsilyl)maleate)
[9], and more recently in its apo form [10]. Interestingly, the
crystal structures of FumC–citrate complexes reveal near the ac-
tive site (or ‘site A’) a second binding site (named as ’site B’)
containing a substrate malate molecule [8,9,11]. However, none
of these structures correspond to a Michaelis complex, thus pre-
venting a more exhaustive analysis of the catalytic mechanism.
Here we report the crystal structures of Mycobacterium tubercu-
losis Rv1098c, another class II fumarase, in complex with
L-malate, fumarate and the competitive inhibitor meso-tartrate.
These structures allow a full analysis of the interactions
between the substrate and the previously proposed catalytic
residues, and they highlight the signiﬁcant conformational
changes that are promoted by ligand binding.lsevier B.V. All rights reserved.
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2.1. Cloning, expression and puriﬁcation
The Rv1098c coding sequence [12] was ampliﬁed by PCR from
the genomic DNA of M. tuberculosis H37Rv and cloned into the
E. coli expression vector pDEST17 (Gateway technology, Invitro-
gen) with the insertion of a N-terminal TEV cleavage site, leading
to the plasmid pDEST-Rv1098c. The same plasmid was used as
PCR template for site-directed mutagenesis by the QuikChange
protocol (Agilent). E. coli BL21(DE3)pLysS cells transformed with
pDEST-Rv1098c or one of the mutated plasmids were grown at
30 C followed by induction with 1 mM IPTG for 18 h at 14 C. Cells
were harvested by centrifugation and lysed by passing through a
French press. After clariﬁcation, the supernatant was loaded onto
a HisTrap FF column (GE Healthcare) and the His6-tagged protein
eluted by a linear gradient of imidazole (10–500 mM). The eluted
protein, diluted to 0.5 mg/ml in 50 mM Tris–HCl buffer, pH 8.0,
containing 100 mM NaCl and 1 mM b-mercaptoethanol, was incu-
bated with His6-tagged TEV protease at a protein-TEV ratio (w/w)
of 1:7 for 6 h at 18 C. The digestion mixture was then passed
through a HisTrap FF column to separate the cleaved protein from
the cut His6 tag and the protease. Finally, the ﬂow-through fraction
containing the tag-free protein was concentrated to 15 mg/ml
and stored at 80 C.
2.2. Crystallization and data collection
Crystallization screening was carried out using the sitting-drop
vapor diffusion method and a Cartesian nanolitre dispensing crys-
tallization robot. After extensive screening and optimization, the
apo-enzyme (wt) crystals used for soaking experiments were ob-
tained by hanging drop by mixing 2 ll of protein at 10 mg/ml with
2 ll of crystallization solution containing 26.5% (v/v) PEG400, 5%
(v/v) glycerol, 200 mM CaCl2 and 100 mM Tris–HCl (pH 8.6). Soak-
ing experiments were carried out in the crystallization solution
supplemented with 20 mM fumarate. Crystals of Rv1098c in com-
plex with meso-tartrate were obtained by cocrystallization of 2 ll
of protein solution at 14 mg/ml (containing 50 mM meso-tartrate)
with 2 ll of crystallization solution containing 10% (w/v) PEG8K,
20% (v/v) glycerol, 200 mM CaCl2 and 100 mM Tris–HCl (pH 8.0).
The same condition was also used to grow crystals of the apo form
of the S318A mutant, whereas crystals of the S318C mutant were
obtained by sitting drop with a Mosquito nanolitre-dispensing ro-
bot (TTP Labtech) by mixing equal volumes of 15 mg/ml enzyme
with 20% (w/v) PEG3350, 200 mM CaCl2. In all cases, crystals were
ﬂash-frozen in liquid nitrogen using a solution of mother liquor as
the cryoprotectant, except for S318C samples for which 25% glyc-
erol was added. X-ray diffraction data were collected either at
the beamline Proxima 1, Synchrotron Soleil (Saint-Aubin, France)
or at ID23-2, ESRF (Grenoble, France) from single crystals at
100 K. Diffraction data were processed using either iMOSFLM
[13] or XDS [14] and scaled with SCALA from the CCP4 program
suite [15].
2.3. Structure determination and reﬁnement
Crystal structures of the Rv1098c complexes with malate and
meso-tartrate were solved by molecular replacement using Phaser
[16] and the PDB entry 3NO9 as the search model. The C-terminal
domains were removed from the model during the ﬁrsts rounds of
reﬁnement and the model was rebuilt through iterative cycles of
manual model building with COOT [17] and reﬁnement with either
phenix.reﬁne [18] or BUSTER [19]. The structures of the S318A and
S318C mutants were solved by molecular replacement using thereﬁned coordinates of protein atoms from either the Rv1098c–L-
malate complex (for S318A) or the meso-tartrate complex (for
S318C). Ligand molecules were manually placed in the mFo–DFc
sigma-A-weighted electron density maps using COOT, and the
resulting models reﬁned as above. Models were validated through
the Molprobity server (http://molprobity.biochem.duke.edu) [20].
Figures were generated and rendered with Pymol 1.3 (Schrödinger,
LLC); two-dimensional representations of protein–ligand interac-
tions were generated with the Poseview server (http://poseview.
zbh.uni-hamburg.de/poseview) [21], with slight modiﬁcations.
Coordinates and structure factors have been deposited in the Pro-
tein Data Bank under the accession codes 4ADL (L-malate com-
plex), 4ADM (meso-tartrate complex), 4APA (S318A mutant) and
4APB (S318C mutant in complex with fumarate).
3. Results
3.1. Overall structure
In contrast to E. coli possessing two class I fumarases (FumA/
FumB) and one class II fumarase (FumC), in theM. tuberculosis gen-
ome the essential gene rv1098c [22], homolog to E. coli fumC, is the
only gene coding for this enzymatic function [12]. We determined
ﬁrst the crystal structure of M. tuberculosis Rv1098c in complex
with the competitive inhibitor meso-tartrate and the substrate
L-malate. Both structures were determined by molecular replace-
ment using the coordinates of the free enzyme (PDB entry
3NO9), deposited by J. Sacchettini and collaborators from the TB
Structural Genomics Consortium (http://www.webtb.org), as the
search model. The crystal structure of Rv1098c-malate complex
at 2.2 Å resolution was obtained by soaking crystals of the free en-
zyme that were isomorphic with the monoclinic crystal form of the
deposited coordinates. In contrast, crystals of the complex with
meso-tartrate, obtained by co-crystallization, belong to a different
crystal form and diffract to signiﬁcantly higher resolution
(1.65 Å; Table 1). As expected for a class II fumarase, the enzyme
assembles as an homo-tetramer with a total mass around 200
kDa. Each subunit consists of three domains: an N-terminal do-
main, a large central a-helical domain and a small C-terminal do-
main (Fig. 1). The N-terminal domain (residues 1–137) is formed
by a compact ﬁve-helix bundle ﬂanked by two strands. The mostly
helical central domain comprises residues 138–393, including the
putative catalytic base His187, and the tight, roughly parallel pack-
ing of four such domains forms the 20-helix bundle core (40 Å
long) of the tetramer. The small C-terminal domain (residues
394–466) is formed by six short a-helices and shows signiﬁcant
conformational ﬂexibility (see below). Overall, Rv1098c shows
signiﬁcant structural similarity to deposited structures of myco-
bacterial homologs (pdb entries 3RD8, 3RRP and 3QBP, all unpub-
lished; Supplementary Table 1), as well as to other members of this
superfamily, including aspartases, d-crystallins, argininosuccinate
lyases, adenylosuccinate lyases, phenylalanine/histidine ammo-
nia-lyases and 3-carboxy-cis,cis-muconate cycloisomerases (data
not shown).
3.2. Conformational changes upon ligand binding
Whereas the ligand-free enzyme possesses 222 point symme-
try, the meso-tartrate-bound tetramers are asymmetric. The asym-
metry comes from large rotations (about 34) around the hinge
residues Ser407 and Asp459 that belong to the C-terminal domain
(Fig. 2); these rotations only occur in two opposing monomers.
Most likely, the asymmetry of these complexes is attributable to
crystal packing forces that preclude conformational transitions
to occur on the remaining C-terminal domains. Indeed, similar
Table 1
Data collection and reﬁnement statistics. Highest resolution shell is shown in parentheses.
meso-tartrate complex L-Malate complex S318A apo S318C-fumarate complex
Data collection
Beamline Proxima 1 (SOLEIL) ID23-2 (ESRF) Proxima 1 (SOLEIL) Proxima 1 (SOLEIL)
Space group C2 C2 C2 P212121
Cell dimensions
a, b, c (Å) 189.10, 96.56, 139.87 271.85, 98.16, 90.13 268.27, 97.14, 96.43 98.00, 98.74, 188.17
a, b, c () 90.00, 112.42, 90.00 90.00, 101.35, 90.00 90.00, 104.54, 90.00 90.00, 90.00, 90.00
Resolution (Å) 41.63–1.65 (1.74–1.65) 46.84–2.20 (2.32–2.20) 43.67–2.04 (2.16–2.04) 49.37–1.94 (2.04–1.94)
Rmerge 0.085 (0.539) 0.123 (0.432) 0.078 (0.484) 0.079 (0.426)
I/r 8.2 (2.6) 7.6 (2.7) 13.1 (2.3) 11.4 (3.2)
Completeness (%) 99.7 (100.0) 98.1 (93.3) 97.9 (86.8) 99.4 (97.8)
Multiplicity 3.6 (3.6) 3.3 (2.8) 4.2 (2.7) 3.4 (3.4)
Reﬁnement
Resolution (Å) 24.16–1.65 22.18–2.20 43.41–2.04 49.37–1.94
No. reﬂections 276381 116132 148043 134762
Rwork/Rfree 0.1627/0.1850 0.1550/0.1781 0.1654/0.1791 0.1474/0.1745
No. atoms
Protein 13335 13508 12904 13533
Ligand/ion 32 18 – 35
Solvent 1689 1271 798 1661
Average B-factors (Å2)
Protein 27.4 27.6 34.2 26.7
Ligand/ion 29.1 34.2 – 25.6
Solvent 40.9 34.5 35.0 35.0
R.m.s. deviations
Bond lengths (Å) 0.006 0.010 0.010 0.010
Bond angles () 0.999 1.010 0.970 0.960
aRmerge ¼
P
jjbIh  Ih;jjPh;jIh;j where bIh ¼ PjIh;j
 
=nh and nh is the multiplicity of reﬂection h.
bR-factor=
P
hklkFoj  jFck=
P
hkljFoj;Rfree: same for the test set (5% of total reﬂections).
Fig. 1. Overall structure of Rv1098c. (A) Ribbon/surface diagram of the Rv1098c homotetramer. The four active sites are located at clefts delimitated by residues belonging to
three distinct subunits. (B) Top view. The four central domains assemble into a 40 Å-long 20 helix-bundle that makes the core of the molecule.
1608 A.E. Mechaly et al. / FEBS Letters 586 (2012) 1606–1611structural changes were also observed in the complex with malate,
which was determined from crystals of the apo enzyme soaked in a
solution containing fumarate, indicating that catalytic activity is
observed inside the crystals and suggesting that the observed en-
zyme structural transitions are driven by ligand binding at the ac-
tive site. As a result, two distinct states, i.e. open and closed, can be
deﬁned on the basis of the active site accessibility. In the closed
state, which is only observed in the presence of a bound ligand, alid comprising residues Pro316-Val325, so called the SS-loop
(due to the presence of two adjacent conserved serines) covers
the active site cleft and interacts with the substrate, as a result of
the aforementioned conformational changes (Fig. 2). It is worth
noting that this loop, bearing residues already known to be crucial
for ligand binding and activity [5,23], is ﬂoppy in the apo structure,
where it could not be traced due to the lack of supporting electron
density.
Fig. 2. Superposition between Rv1098c in the apo state and in complex with L-malate, highlighting the open to close conformational transition that involves a 34 inward
rotation of the C-terminal domain in the presence of the ligand. The SS-loop (residues Pro316-Val325), bearing key catalytic residues and disordered in the apo structure, is
indicated by the arrow.
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positioned at a cleft formed by residues belonging to three sub-
units and was ﬁrst identiﬁed from the extensive structural and bio-
chemical analysis of E. coli FumC [7]. The crystal structure of
Rv1098c with meso-tartrate, a known competitive inhibitor of
fumarases including the close Rv1098c homolog from Corynebacte-
rium glutamicum [24], showed clear Fourier difference density for
the bound compound in two out of the four available active sites
(Fig. 3A). In particular, one of the meso-tartrate molecules forms
a number of hydrogen bonding interactions with Ser104, Thr106,
Ser138, Ser139 and Asn140 from subunit A, with Thr186 and
His187 from subunit B and Ser318, Ser319, Lys324 and Asn326Fig. 3. Active site environment. Interactions between meso-tartrate (SRT; panels A and B
site residues in Rv1098c. Sigma-A weighted difference electron density maps (mFo–DFc),
shown as a green mesh.from subunit C (Fig. 3A and B), while the second-one forms equiv-
alent hydrogen bonds with the corresponding residues from sub-
units B, A and D, respectively.
Remarkably, the structure of the Rv1098c–malate complex was
obtained by soaking apo-enzyme crystals in a solution containing
fumarate. Nevertheless, the observed Fourier difference density
unambiguously pointed to a bound malate molecule rather than
fumarate, since density compatible with an oxygen atom was
found within covalent binding distance with the C3 carbon, that
shows tetrahedral geometry, and this hydroxyl group further
makes an H-bond with the conserved His187 (Fig. 3C and D). In
fact, L-malate is bound in the same orientation and by means of), L-malate (LMR: panels C and D) or fumarate (FMR; panels E and F) and the active
calculated before each ligand was added to the model and contoured at 3r level, are
1610 A.E. Mechaly et al. / FEBS Letters 586 (2012) 1606–1611the same protein–ligand interactions as meso-tartrate in the en-
zyme–inhibitor complex (Fig. 3D). The unpublished structure of
Mycobacterium abscessus fumarase, deposited by a structural
genomics initiative (Seattle Structural Genomics Centre for Infec-
tious Disease) in complex with L-malate as well (pdb entry
3RRP), shows the bound substrate in a perfectly conserved active
site environment with respect to Rv1098c. However, the four sub-
units in this structure are all found in the closed state, consistently
with the presence of L-malate in the four available active sites
(Supplementary Table 1 and Fig. 1).
3.3. Ser318 is a catalytic key residue
Several reports have shown experimental evidence pointing to a
stepwise acid–base catalytic mechanism for class II fumarases,
which proceeds through the generation of an aci-carbanion inter-
mediate [25]. Although the role of the strictly conserved His187
(Rv1098c numbering) as one of the two acid–base catalysts in
the reaction is generally agreed, the identiﬁcation of other one is
still matter of debate. Inspection of the mycobacterium active site
suggests Ser318 as the most likely candidate, given the favorable
distance (3.2 Å) and orientation for the abstraction of a proton
from the b-carbon of malate by the Ser Oc oxygen, as seen in the
Michaelis complex (Fig. 3C). On the basis of similar observations,
the equivalent serine has been proposed as a catalytic residue in
duck d2 crystallin [3], E. coli adenylosuccinate lyase [5] and Bacillus
aspartase [26]. To validate this hypothesis in M. tuberculosis fuma-
rase, we mutated Ser318 to either alanine or cysteine. Both mu-
tants show no detectable activity when supplied with fumarate,
in contrast to the wild-type enzyme (Fig. 4). Moreover, the crystal
structures of both mutants were solved. The structure of the
S318A, obtained at 2.04 Å resolution from a crystal isomorphic to
the wt apo form (Table 1), shows the enzyme with no ligands
and the four active sites in the open conformation, the whole mod-
el being well superimposable to the wt apo structure
(r.m.s.d. = 0.486 Å as for the Ca atoms with respect to the pdb entry
3NO9). In contrast, the structure of the S318C mutant, reﬁned at
1.94 Å resolution on data collected from crystals belonging to aFig. 4. Enzymatic activity assays were performed at 25 C in 100 mM Tris–HCl pH
8.0, 200 mM NaCl by following the decrease in absorbance at 250 nm, correspond-
ing to the fumarate consumption [27]. The protein concentration used for these
tests was 4.5 lg/ml for the wt enzyme (), 37.5 lg/mul for the S318C mutant (N)
and 95 lg/ml for the S318A mutant (j). Fumarate was supplied at a ﬁxed
concentration of 14 mM.different space group (Table 1), shows unambiguousmFo–DFc den-
sity for fumarate in all active sites (Fig. 3E), despite no such mole-
cule was added during the puriﬁcation and crystallization steps.
The fumarate substrate is bound with both carboxylate groups
superimposable to those of L-malate and meso-tartrate in their
respective complexes, as expected, and shows the same interac-
tions with the active site residues as L-malate (Fig. 3F). Moreover,
the four active sites within the enzyme tetramer are now all found
in the closed conformation, consistently with the presence of the
substrate and similarly to the structure of the M. abscessus fuma-
rase cocrystallized with L-malate (3RRP), which shows the highest
structural similarity (r.m.s.d. = 0.427 Å for the Ca atoms; Supple-
mentary Table 1 and Fig. 1).
4. Discussion
Unlike previously reported crystal structures of class II fumaras-
es, the ensemble of Rv1098c structures allows the deﬁnition of an
open and a closed state of the enzyme. The open state refers to a
conformation in which the small C-terminal domain adopts an ori-
entation similar to previously described structures in the apo form,
the active site cleft being accessible to solvent, whereas the closed
state is characterized by an inward bending of a part of the C-
terminal domain (Fig. 2). This conformational transition is most
likely triggered by the occupation of the catalytic cleft by the sub-
strate. In agreement with our model, similar conformational
changes involving the SS-loop and a rigid-body movement of C-
terminal domain were observed in duck d1 crystallin with a sulfate
ion bound in the active site, and suggested to be driven by sub-
strate binding [3] (Supplementary Fig. 2). More recently, closure
of the SS-loop upon the bound substrate has also been reported
for Bacillus sp. YM55-1 aspartase (aspartate ammonia lyase) in
complex with L-aspartate, although no signiﬁcant displacement
of the C-terminal domain was observed. In this case, this domain
appeared to increase its mobility (weaker electron density and
higher B factors) in response to the loss of interaction with the
SS-loop in the complexed subunits [26] (Supplementary Fig. 2).
In all cases, the closure of the cleft by the SS-loop lid and possibly
the inward bending of C-terminal domain would contribute signif-
icantly to the sequesterisation of the substrate from the solvent
during the course of the reaction, and might be a general feature
of this superfamily. It is noteworthy that the SS-loop closure is
essential for the correct positioning of the key Ser318 residue.
Although the role of this residue as one of the two acid/base cata-
lysts is supported by mutagenesis, in agreement with previous
observations in other members of this superfamily [5,26], many
mechanistic aspects of the reaction remain poorly understood,
notably how the pKa of a serine side chain might be lowered en-
ough to act as an acid/base. As previously suggested for adenylo-
succinate lyase, hydrogen bonding to the main chain amide
groups of the neighboring Ile320 and Met321 (also part of the
SS-loop), as well as to the b-carboxylate group from the substrate
might play a role [5,26].
The major structural difference between Rv1098c and E. coli
FumC is the absence, in the mycobacterial enzyme, of a loop com-
prising residues Leu117 to Vall28 (FumC numbering), which in the
E. coli enzyme contributes to structure the so-called ’site B’ about
12 Å away from the active site (Fig. 5). It is noteworthy that a ma-
late molecule was found to bind to this site in FumC crystals con-
taining citrate at the active site, proposing this region as either an
allosteric activator site [9] or as part of the active site, possibly in-
volved in the channeling of the substrate or the release of the prod-
uct [11]. It is therefore tempting to speculate that no such B site
may be present in Rv1098c, as, in addition to the absence of the
Leu117–Val128 loop, no density attributable to a ligand could be
Fig. 5. Superposition of the B site pocket of E. coli FumC with an L-malate molecule
bound (pdb entry 1FUR; [9]), depicted in light blue, the same in the ligand-free
enzyme (pdb entry 1YFE; [10]), in violet, and the corresponding region in the
Michaelis complex of M. tuberculosis Rv1098c with L-malate, in yellow (this work).
The side chain of the conserved His128 in Rv1098c is oriented inside the pocket, as
it is also observed in FumC in the absence of ligand [10]. The amino acid sequence
alignment, limited to the region of Leu117–Val125 loop in FumC, is shown at the
bottom.
A.E. Mechaly et al. / FEBS Letters 586 (2012) 1606–1611 1611observed in the equivalent pocket in any of the Rv1098c structures.
Consistently with the absence of ligands, His128, the equivalent to
E. coli FumC His129 that seems to be a key component of the B site
[8,9,11], positions its side chain inside the putative site, as ob-
served in the ligand-free structure of the E. coli enzyme [10]
(Fig. 5). However, since a pH-dependent gating mechanism has
been proposed to control the access to the B site in FumC through
the His129 side chain [10], we cannot rule out the presence of a
functional B site in mycobacterial fumarases, given the basic pH
(>8.0) at which the Rv1098c crystals have been obtained. Whether
different regulatory mechanisms may operate on these enzymes,
possibly in response to changes in the overall metabolic state of
the bacterial cell, remains to be established.
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